MedPath

Effect of Peppermint on nausea, vomiting and anorexia in patients with breast cancer under chemotherapy

Not Applicable
Conditions
ausea and vomiting.
Nausea and vomiting
Registration Number
IRCT20130731014229N7
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
84
Inclusion Criteria

Satisfaction to participate in the study
Diagnosis of breast cancer
History of receiving a chemotherapy course
Experience nausea following previous chemotherapy

Exclusion Criteria

Unwillingness to continue participating in the study
Forgetting the use of Peppermint in three times

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS scale.;Vomiting. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: Frequency table.;Anorexia. Timepoint: At the beginning of the study (before the intervention) and immediately, 24 and 48 hours after the end of the chemotherapy. Method of measurement: VAS Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath